Paper39650663
Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer.
Guo X and 6 others. Front Immunol, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer. Papers, record 39650663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39650663
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Anoikis | Major topic |
| Precision Medicine | Major topic |
| Machine Learning | Major topic |
| Humans | |
| Female | |
| Prognosis | |
| Biomarkers, Tumor | |
| Gene Expression Profiling | |
| Transcriptome | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29092952 | TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Cancer Res | 2017 | https://conductscience.org/library/papers/29092952 | PubMed |
| 2 | 32124324 | EPIC: A Tool to Estimate the Proportions of Different Cell Types from Bulk Gene Expression Data. | Methods Mol Biol | 2020 | https://conductscience.org/library/papers/32124324 | PubMed |
| 3 | 36282174 | Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. | Elife | 2022 | https://conductscience.org/library/papers/36282174 | PubMed |
| 4 | 31604482 | MetaCell: analysis of single-cell RNA-seq data using K-nn graph partitions. | Genome Biol | 2019 | https://conductscience.org/library/papers/31604482 | PubMed |
| 5 | 27765066 | Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. | Genome Biol | 2016 | https://conductscience.org/library/papers/27765066 | PubMed |
| 6 | 16199517 | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16199517 | PubMed |
| 7 | 30954475 | DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. | Cell Syst | 2019 | https://conductscience.org/library/papers/30954475 | PubMed |
| 8 | 38504988 | Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making. | Front Immunol | 2024 | https://conductscience.org/library/papers/38504988 | PubMed |
| 9 | 29083409 | Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. | Nat Genet | 2017 | https://conductscience.org/library/papers/29083409 | PubMed |
| 10 | 28836703 | Anoikis resistance and oncoviruses. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/28836703 | PubMed |
| 11 | 29262807 | A metastatic invasive mole arising from iatrogenic uterus perforation. | BMC Cancer | 2017 | https://conductscience.org/library/papers/29262807 | PubMed |
| 12 | 36143281 | Application of Artificial Intelligence Techniques to Predict Risk of Recurrence of Breast Cancer: A Systematic Review. | J Pers Med | 2022 | https://conductscience.org/library/papers/36143281 | PubMed |
| 13 | 26312921 | Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms. | Lancet | 2015 | https://conductscience.org/library/papers/26312921 | PubMed |
| 14 | 35154121 | Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures. | Front Immunol | 2022 | https://conductscience.org/library/papers/35154121 | PubMed |
| 15 | 25098270 | Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/25098270 | PubMed |
| 16 | 14702756 | [Anoikis--a specific form of programmed cell death]. | Harefuah | 2003 | https://conductscience.org/library/papers/14702756 | PubMed |
| 17 | 20606088 | Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20606088 | PubMed |
| 18 | 31819264 | NicheNet: modeling intercellular communication by linking ligands to target genes. | Nat Methods | 2020 | https://conductscience.org/library/papers/31819264 | PubMed |
| 19 | 33771684 | Fibronectin regulates anoikis resistance via cell aggregate formation. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33771684 | PubMed |
| 20 | 31126321 | Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. | Genome Med | 2019 | https://conductscience.org/library/papers/31126321 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41550348 | Evaluating AI-driven precision oncology for breast cancer in low- and middle-income countries: a review of machine learning performance, genomic data use, and clinical feasibility. | Front Digit Health | 2025 | https://conductscience.org/library/papers/41550348 | PubMed |
| 40442841 | Revolutionizing breast cancer immunotherapy by integrating AI and nanotechnology approaches: review of current applications and future directions. | Bioelectron Med | 2025 | https://conductscience.org/library/papers/40442841 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39650663
GET https://conductscience.org/api/papers/v1/39650663/references?page=2